Huber Needles Industry - Regional Synopsis
North America is projected to hold largest huber needles market share by the end of 2037, backed by significant propagation in chemotherapy and dialysis processes on account of major surge in lifestyle diseases, such as, diabetes, along with increasing count of various chronic disorders. For instance, approximately 790,000 individuals in the United States developed ESKD, also widely recognized as an end-stage renal disease (ESRD), in 2020, with 75% were receiving dialysis and 30% receiving a kidney transplant.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Huber Needles Market in 2025 is estimated at USD 55.23 million.
The global market size was worth over USD 51.44 million in 2024 and is poised to grow at a CAGR of around 9.2%, reaching USD 161.51 million revenue by 2037.
North America is estimated to lead, fueled by rising chemotherapy and dialysis treatments due to chronic and lifestyle diseases.
The major players in the market include B. Braun Medical Inc, .ICU Medical, Inc., Baxter International, Inc., Nipro Medical Corporation, Becton, Dickinson and Company, AngioDynamics, Inc., Vygon SAS, EXELINT International, Co., Medtronic, Terumo Corporation.
